- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/166 - Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon atom of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
Patent holdings for IPC class A61K 31/166
Total number of patents in this class: 2026
10-year publication summary
|
151
|
145
|
137
|
140
|
121
|
128
|
124
|
252
|
175
|
87
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| SpringWorks Therapeutics, Inc. | 156 |
55 |
| The Regents of the University of California | 20720 |
22 |
| Evoke Pharma, Inc. | 30 |
20 |
| Centre National de La Recherche Scientifique | 11016 |
19 |
| Merck Sharp & Dohme LLC | 3735 |
18 |
| Entera Bio Ltd. | 50 |
17 |
| University of Florida Research Foundation, Inc. | 4173 |
16 |
| Duke University | 3184 |
16 |
| Children's Medical Center Corporation | 1956 |
16 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 3219 |
16 |
| The Johns Hopkins University | 5875 |
15 |
| Emeramed Limited | 17 |
15 |
| The Board of Trustees of the Leland Stanford Junior University | 6644 |
14 |
| The General Hospital Corporation | 4858 |
14 |
| Dana-Farber Cancer Institute, Inc. | 2662 |
14 |
| Institut Curie | 615 |
12 |
| Arvinas Operations, Inc. | 261 |
12 |
| Ohio State Innovation Foundation | 2366 |
11 |
| Vanderbilt University | 2019 |
11 |
| Bristol-myers Squibb Company | 4729 |
10 |
| Other owners | 1683 |